<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">12813</article-id><article-id pub-id-type="doi">10.7554/eLife.12813</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-45761"><name><surname>Steger</surname><given-names>Martin</given-names></name><aff><institution content-type="dept">Department of Proteomics and Signal Transduction</institution>, <institution>Max Planck Institute of Biochemistry</institution>, <addr-line><named-content content-type="city">Martinsried</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45762"><name><surname>Tonelli</surname><given-names>Francesca</given-names></name><aff><institution content-type="dept">Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences</institution>, <institution>University of Dundee</institution>, <addr-line><named-content content-type="city">Dundee</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45763"><name><surname>Ito</surname><given-names>Genta</given-names></name><aff><institution content-type="dept">Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences</institution>, <institution>University of Dundee</institution>, <addr-line><named-content content-type="city">Dundee</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45764"><name><surname>Davies</surname><given-names>Paul</given-names></name><aff><institution content-type="dept">Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences</institution>, <institution>University of Dundee</institution>, <addr-line><named-content content-type="city">Dundee</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45765"><name><surname>Trost</surname><given-names>Matthias</given-names></name><aff><institution content-type="dept">Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences</institution>, <institution>University of Dundee</institution>, <addr-line><named-content content-type="city">Dundee</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45766"><name><surname>Vetter</surname><given-names>Melanie</given-names></name><aff><institution content-type="dept">Department of Structural Cell Biology</institution>, <institution>Max Planck Institute of Biochemistry</institution>, <addr-line><named-content content-type="city">Martinsried</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45767"><name><surname>Wachter</surname><given-names>Stefanie</given-names></name><aff><institution content-type="dept">Department of Structural Cell Biology</institution>, <institution>Max Planck Institute of Biochemistry</institution>, <addr-line><named-content content-type="city">Martinsried</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-43222"><name><surname>Lorentzen</surname><given-names>Esben</given-names></name><aff><institution content-type="dept">Department of Structural Cell Biology</institution>, <institution>Max Planck Institute of Biochemistry</institution>, <addr-line><named-content content-type="city">Martinsried</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45768"><name><surname>Duddy</surname><given-names>Graham</given-names></name><aff><institution>The Wellcome Trust Sanger Institute</institution>, <addr-line><named-content content-type="city">Hinxton</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45769"><name><surname>Wilson</surname><given-names>Stephen</given-names></name><aff><institution content-type="dept">RD Platform Technology and Science</institution>, <institution>GlaxoSmithKline Pharmaceuticals R&amp;D</institution>, <addr-line><named-content content-type="city">Stevenage</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-45770"><name><surname>Baptista</surname><given-names>Marco AS</given-names></name><aff><institution>The Michael J. Fox Foundation for Parkinson's Research</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45771"><name><surname>Fiske</surname><given-names>Brian K</given-names></name><aff><institution>The Michael J. Fox Foundation for Parkinson's Research</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45772"><name><surname>Fell</surname><given-names>Matthew J</given-names></name><aff><institution content-type="dept">Early Discovery Neuroscience</institution>, <institution>Merck Research Laboratories</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-45773"><name><surname>Morrow</surname><given-names>John A</given-names></name><aff><institution content-type="dept">Neuroscience</institution>, <institution>Merck Research Laboratories</institution>, <addr-line><named-content content-type="city">Westpoint</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-45774"><name><surname>Reith</surname><given-names>Alastair D</given-names></name><aff><institution content-type="dept">Neurodegeneration Discovery Performance Unit</institution>, <institution>GlaxoSmithKline Pharmaceuticals R&amp;D</institution>, <addr-line><named-content content-type="city">Stevenage</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-5514"><name><surname>Alessi</surname><given-names>Dario R</given-names></name><aff><institution content-type="dept">Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences</institution>, <institution>University of Dundee</institution>, <addr-line><named-content content-type="city">Dundee</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-2199"><name><surname>Mann</surname><given-names>Matthias</given-names></name><aff><institution content-type="dept">Department of Proteomics and Signal Transduction</institution>, <institution>Max Planck Institute of Biochemistry</institution>, <addr-line><named-content content-type="city">Martinsried</named-content></addr-line>, <country>Germany</country><email>mmann@biochem.mpg.de</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1078"><name><surname>Dikic</surname><given-names>Ivan</given-names></name><role>Reviewing editor</role><aff><institution>Goethe University Medical School</institution>, <country>Germany</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>29</day><month>01</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e12813</elocation-id><supplementary-material><ext-link xlink:href="elife-12813-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>03</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>21</day><month>01</month><year>2016</year></date></history><permissions><copyright-statement>Â© 2016, Steger et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Steger et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Mutations in Park8, encoding for the multidomain Leucine-rich repeat kinase 2 (LRRK2) protein, comprise the predominant genetic cause of Parkinson's disease (PD). G2019S, the most common amino acid substitution activates the kinase two to three-fold. This has motivated the development of LRRK2 kinase inhibitors; however, poor consensus on physiological LRRK2 substrates has hampered clinical development of such therapeutics. We employ a combination of phosphoproteomics, genetics and pharmacology to unambiguously identify a subset of Rab GTPases as key LRRK2 substrates. LRRK2 directly phosphorylates these both <italic>in vivo</italic> and <italic>in vitro</italic> on an evolutionary conserved residue in the switch II domain. Pathogenic LRRK2 variants mapping to different functional domains increase phosphorylation of Rabs and this strongly decreases their affinity to regulatory proteins including Rab GDP dissociation inhibitors (GDIs). Our findings uncover a key class of bona-fide LRRK2 substrates and a novel regulatory mechanism of Rabs that connects them to PD.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Stephen Wilson, Employees of GlaxoSmithKline, a global healthcare company that may conceivably benefit financially through this publication.</p></fn><fn fn-type="conflict" id="conf3"><p>Matthew J Fell, Employee of Merck, a global healthcare company that may conceivably benefit financially through this publication..</p></fn><fn fn-type="conflict" id="conf4"><p>John A Morrow, employees of Merck Research Laboratories.</p></fn><fn fn-type="conflict" id="conf5"><p>Alastair D Reith, Employee of GlaxoSmithKline, a global healthcare company that may conceivably benefit financially through this publication.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal studies were ethically reviewed and carried out in accordance with Animals (Scientific Procedures) Act 1986, the GSK Policy on the Care, Welfare and Treatment of Animals, regulations set by the University of Dundee and the U.K. Home Office. Animal studies and breeding were approved by the University of Dundee ethical committee and performed under a U.K. Home Office project license.</p></fn></fn-group></back></article>